Skip to main content
Top
Published in: Breast Cancer Research 2/2006

01-11-2006 | Poster Presentation

Increased regulatory T-cell numbers distinguish high-risk breast cancer patients and those at risk of late relapse

Authors: GJ Bates, SB Fox, C Han, RD Leek, JF Garcia, AL Harris, AH Banham

Published in: Breast Cancer Research | Special Issue 2/2006

Login to get access

Excerpt

We aimed to assess the clinical significance of tumour-infiltrating FOXP3+ regulatory T cells (TR) in breast cancer patients with long-term follow-up. …
Metadata
Title
Increased regulatory T-cell numbers distinguish high-risk breast cancer patients and those at risk of late relapse
Authors
GJ Bates
SB Fox
C Han
RD Leek
JF Garcia
AL Harris
AH Banham
Publication date
01-11-2006
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2006
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1586

Other articles of this Special Issue 2/2006

Breast Cancer Research 2/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine